Simplex Trading
MLYS icon

Simplex Trading’s Mineralys Therapeutics MLYS Stock Holding History

Simplex Trading’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$279K Buy
10,300
+9,800
+1,960% +$287K ﹤0.01% 3902
2025
Q4 		$18.1K Sell
500
-2,600
-84% -$104K ﹤0.01% 6569
2025
Q3 		$117K Buy
3,100
+2,200
+244% +$47.6K ﹤0.01% 5560
2025
Q2 		$12K Sell
900
-5,000
-85% -$72.5K ﹤0.01% 7178
2025
Q1 		$93K Buy
5,900
+5,800
+5,800% +$66.7K ﹤0.01% 5123
2024
Q4 		$1K Sell
100
-600
-86% -$7.85K ﹤0.01% 8259
2024
Q3 		$8K Sell
700
-900
-56% -$10.9K ﹤0.01% 7343
2024
Q2 		$18K Buy
+1,600
New +$20.2K ﹤0.01% 6984

Other funds holding MLYS

CP
Catalys Pacific Tokyo, Japan $231M AUM 83.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Simplex Trading's MLYS Position: Q1 2026 in Review

Simplex Trading increased its Mineralys Therapeutics (MLYS) stake by 307% in Q1 2026, buying an estimated $433K and bringing the position to 19,562 shares worth $530K. The position accounts for ﹤0.01% of the portfolio, ranked #3187.

Simplex Trading first reported a position in MLYS in Q3 2024 and has held it in 6 quarters since. 214 funds tracked by Wall St. Rank hold MLYS as of Q1 2026.

  • Simplex Trading held 19,562 shares of Mineralys Therapeutics worth $530K as of Q1 2026.
  • Simplex Trading bought 14,760 Mineralys Therapeutics shares in Q1 2026, an estimated $433K.
  • Mineralys Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3187 holding.
  • Simplex Trading first reported a position in Mineralys Therapeutics in Q3 2024 and has held it in 6 quarters since.
  • 214 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.